苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)

收藏
检测样品: 化药新药研发
检测项目: 从HPLC转移至UHPLC
浏览次数: 351
发布时间: 2016-07-21
关联设备: 1种 查看全部
获取电话
留言咨询
方案下载

安捷伦科技(中国)有限公司

钻石23年

解决方案总数: 3278 方案总浏览次数:
方案详情
Over the last decades, an increasing number of generic drug formulations have been released on the pharmaceutical market. These products are generally analyzed with compendia methods. This Application Note describes the method transfer of a USP HPLC method for amlodipine besylate tablets to a state-of-the-art UHPLC method. Adjustments on column dimension and method parameters were carried out within the permitted limits in order to avoid the need for a lengthy revalidation process. The Agilent 1290 Infinity II LC facilitated smooth transfer from one method to the other. System suitability criteria were investigated and met with both HPLC and UHPLC.

方案详情

确定

该文件无法预览

请直接下载查看

产品配置单

安捷伦科技(中国)有限公司为您提供《苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)》,该方案主要用于化药新药研发中从HPLC转移至UHPLC检测,参考标准--,《苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)》用到的仪器有Agilent 1290 Infinity II 液相色谱系统